MPM Bioventures 2018, L.P., 10% Owner at iTeos Therapeutics, Inc. (ITOS), sold 67,858 shares at $27.47 ($1.9M) on 2021-09-21, disclosed to the SEC on 2021-09-23.
Open-market sale of $1.9M ITOS by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.47 | 19,635 | $539K | 28.9% |
| 2 | $27.47 | 19,635 | $539K | 28.9% |
| 3 | $27.54 | 14,294 | $394K | 21.1% |
| 4 | $27.54 | 14,294 | $394K | 21.1% |
| Total | $27.50 avg | 67,858 | $1.9M | 100% |
| Filing → |
| TRDA | SELL | 2026-08-31 | $616K | — | Filing → |
| TRDA | SELL | 2026-08-26 | $462K | — | Filing → |
| AKTS | BUY | 2026-01-14 | $20.0M | — | Filing → |